查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1529986

全球醫療事務外包市場：按服務、按行業、按地區

Medical Affairs Outsourcing Market, By Services (Medical Writing & Publishing, Medical Monitoring, Medical Science Liaisons, Medical Information, Others), By Industry, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 172 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計2024年全球醫療事務外包市場規模將達23.1億美元，2024年至2031年複合年成長率為12.3%，2031年將達52.1億美元。

報告範圍 報告詳情
基準年 2023年 2024年市場規模 23.1億美元
實際資料 2019-2023 預測期 2024-2031
預測 2024-2031 年複合年成長率： 12.30% 2031 年金額預測 52.1億美元
圖.醫療事務外包市場佔有率（%）（依地區分類，2024年）
醫療事務外包市場-IMG1

不斷上升的藥物開發成本和複雜的監管要求正在增加製藥和生物技術公司對外部專業知識和服務的依賴。醫療事務外包有助於降低開發成本並加速臨床試驗和新產品的推出。公司可以從外包合作夥伴的專業技能和見解中受益，同時專注於其核心競爭力。提供的服務包括醫療資訊、醫療監測、醫療報告和出版規劃以及監管支援。技術進步正在實現遠端地點的靈活工作模式並擴大外包範圍。持續的數位化和不斷增加的藥物開發研發投資正在推動醫療事務外包市場的成長。

市場動態：

全球醫療事務外包市場的成長是由藥物開發成本上升、監管標準趨嚴以及製藥公司對核心能力的關注等因素所推動的。過去幾十年來，開發新藥的平均成本顯著增加，目前已超過 26 億美國。外包某些功能可以顯著降低成本。全球範圍內的監管要求也變得更加複雜，文件和合規標準也更加嚴格。醫療事務外包使公司能夠利用專業知識有效地應對法規。此外，透過外包非核心業務，公司可以更專注於核心藥物發現和行銷活動。資料安全和關鍵流程失去控制可能會阻礙市場成長。人工智慧和區塊鏈等技術進步透過實現遠端服務和改進的資料管理能力提供了機會。

本研究的主要特點

  • 該報告對全球醫療事務外包市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。正在做。
  • 它還揭示了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
  • 它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球醫療事務外包市場的主要企業。
  • 該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
  • 本報告針對該產業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 透過用於分析全球醫療事務外包市場的各種策略矩陣，將促進相關人員的決策。

目錄

第1章 研究目的與前提

  • 研究目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章 市場動態、法規與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 監管場景
  • 收購和合作場景
  • 資金籌措和投資
  • PEST分析
  • 波特分析

第4章全球醫療事務外包市場－COVID-19 的影響

  • 整體影響
  • 政府舉措
  • COVID-19 對市場的影響

第5章 全球醫療事務外包市場，依服務分類，2019-2031 年（十億美元）

  • 醫學寫作/出版
  • 醫療監測
  • 醫藥學術專員(MSL)
  • 醫療資訊
  • 其他

第6章 全球醫療事務外包市場（按產業），2019-2031 年（十億美元）

  • 製藥
  • 生物製藥
  • 醫療設備

第7章 2019-2031年全球醫療事務外包市場（按地區）（十億美元）

  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東

第8章 競爭格局

  • 公司簡介
    • IQVIA Holdings Inc.
    • Ashfield
    • Syneos Health
    • Parexel International Corporation
    • ICON plc
    • PRA Health Sciences
    • Pharmaceutical Product Development（PPD）
    • WuXi AppTec
    • SGS SA
    • Covance Inc.（part of LabCorp）
    • Indegene
    • The Medical Affairs Company（TMAC）
    • Synergy Pharmaceuticals
    • Charles River Laboratories
    • KOLgroups
    • ZS Associates
    • McKinsey &Company（Healthcare Practice）
    • Accenture

第9章 分析師建議

  • 命運之輪
  • 分析師觀點
  • 一致的機會圖

第10章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI7084

Global medical affairs outsourcing market is estimated to be valued at USD 2.31 Bn in 2024 and is expected to reach USD 5.21 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 12.3% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 2.31 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 12.30% 2031 Value Projection: US$ 5.21 Bn
Figure. Medical Affairs Outsourcing Market Share (%), By Region 2024
Medical Affairs Outsourcing Market - IMG1

Rising drug development costs and complex regulatory requirements have compelled pharmaceutical and biotech companies to increasingly rely on external expertise and services. Medical affairs outsourcing helps to reduce development expenses and speeds up clinical trials and new product launches. It allows companies to stay focused on core competencies while benefitting from specialized skills and insights of outsourcing partners. Various services offered include medical information, medical monitoring, medical reporting and publication planning, along with regulatory support. Advancements in technology have enabled remote and flexible working models, thus, boosting the scope of outsourced activities. Continued digitalization and growing R&D investment in drug development can drive the medical affairs outsourcing market growth.

Market Dynamics:

Global medical affairs outsourcing market growth is driven by factors like rising drug development costs, stringent regulatory norms, and focus on core competencies by pharmaceutical firms. The average cost of developing a new drug has increased substantially over the past few decades to over US$ 2.6 billion currently. Outsourcing certain functions helps to lower costs substantially. Regulatory requirements have also become more complex globally with greater paperwork and compliance standards. Medical affairs outsourcing allows companies to leverage specialized expertise to navigate regulations efficiently. It also allows companies to focus more on core drug discovery and marketing activities while non-core functions are outsourced. Data security and loss of control over critical processes can hamper the market growth. Technological advancements like artificial intelligence and blockchain offers opportunities by enabling remote services and greater data management capabilities.

Key Features of the Study:

  • This report provides in-depth analysis of the global medical affairs outsourcing market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global medical affairs outsourcing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Syneos Health, ICON plc, PRA Health Sciences, The Medical Affairs Company (TMAC), Ashfield Healthcare Communications, Promedica International, Synchrogenix Information Strategies, Anthelio Healthcare Solutions, Pharmaceutical Product Development, LLC. (PPD), and Clinquest Group
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global medical affairs outsourcing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • -Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical affairs outsourcing market

Detailed Segmentation-

  • By Services
    • Medical Writing & Publishing
    • Medical Monitoring
    • Medical Science Liaisons (MSLs)
    • Medical Information
    • Others
  • By Industry
    • Pharmaceutical
    • Biopharmaceutical
    • Medical Devices
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • IQVIA Holdings Inc.
    • Ashfield (part of UDG Healthcare plc)
    • Syneos Health
    • Parexel International Corporation
    • ICON plc
    • PRA Health Sciences
    • Pharmaceutical Product Development (PPD)
    • WuXi AppTec
    • SGS SA
    • Covance Inc. (part of LabCorp)
    • Indegene
    • The Medical Affairs Company (TMAC)
    • Synergy Pharmaceuticals
    • Charles River Laboratories
    • KOLgroups
    • ZS Associates
    • McKinsey & Company (Healthcare Practice)
    • Accenture

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Services
    • Market Snapshot, By Industry
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Medical Affairs Outsourcing Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Medical Affairs Outsourcing Market, By Services, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Medical Writing & Publishing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Medical Monitoring
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Medical Science Liaisons (MSLs)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Medical Information
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Medical Affairs Outsourcing Market, By Industry, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Pharmaceutical
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Biopharmaceutical
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Medical Devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Medical Affairs Outsourcing Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Services, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Industry, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Services, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Industry, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Services, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Industry, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Services, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Industry, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Services, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Industry, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Services, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Industry, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • IQVIA Holdings Inc.
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Ashfield
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Syneos Health
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Parexel International Corporation
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • ICON plc
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • PRA Health Sciences
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Pharmaceutical Product Development (PPD)
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • WuXi AppTec
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • SGS SA
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Covance Inc. (part of LabCorp)
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Indegene
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • The Medical Affairs Company (TMAC)
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Synergy Pharmaceuticals
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Charles River Laboratories
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • KOLgroups
    • ZS Associates
    • McKinsey & Company (Healthcare Practice)
    • Accenture

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. Reference and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact